| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04948106f49489f3435e197b218b959a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29f3c7f70ed27feb0972ad5198b98222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_934eac74ded2a7c9f6c8c75e3cac0bea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2010-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9de9ed67aeac06a3e573e50a3dbe89cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_278ca269779faa725554bbed4bd70a32 |
| publicationDate |
2014-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8785138-B2 |
| titleOfInvention |
Monovalent ligands of the human CD28 receptor |
| abstract |
The invention relates to monovalent ligands of the human CD28 receptor, which can selectively block the interaction between CD28 and B7 without activating the CD28 receptor. Said ligands can be used in particular in the production of immunosuppressant drugs, selectively blocking T lymphocyte activation phenomena involving the CD28 receptor. |
| priorityDate |
2009-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |